“Expert Corner” is a special section on Bamboo Works where executives and professionals from investor relations, public relations, financial services and other related fields can share their expert views and perspectives on the latest trends in their sector. If you are interested in contributing, please contact us at info@thebambooworks.com

New Roles for the Board: Getting Involved in Communications and Corporate Reputation

As boards evolve to take on more functions, their assistance with communications in times of crisis can help to ease the pressure on management By Vivian Lines Covid-19 has brought into sharp relief the expanded role that boards of directors can take to support management and add value to the organization in difficult times. Communication with stakeholders is one way in which boards can augment the work of management.

Read More »

Shenghui Cleanness Looks Like ‘Pandemic Winner’ in Runup to Hong Kong IPO

The cleaning services provider has applied for a Hong Kong IPO, aiming to spread its hygiene expertise to more places in China Key Takeaways: Sanitation specialist Shenghui Cleanness has filed for an IPO in Hong Kong, aiming to use the proceeds to accelerate its expansion The company’s core cleaning services are very labor-intensive, prompting it to look for ways to lower costs through automation and other uses of technology By Lau Ming One man’s pandemic pain is another’s pandemic prevention gain. That modified version of the old adage could well…

Read More »

FAST NEWS: HutchMed Shares Plunge on U.S. Cancer Drug Rejection

The latest: HutchMed (China) Ltd. (HCM.US; 0013.HK) announced late Monday that its Surufatinib drug for the treatment of advanced neuroendocrine tumors was denied approval by the U.S. Food and Drug Administration (FDA). Looking up: The FDA indicated its denial was not related to any safety issues, but instead said that additional multi-regional clinical trials (MRCTs) more representative of the U.S. patient population would be needed to support a U.S. approval. Take Note: The FDA determined that the current data package, based on two positive Phase 3 trials in China and…

Read More »

Full Truck Alliance Shifts Up a Gear on Regulatory Easing Reports

Trucking app operator’s shares have surged 32% over the last two trading days, even as it forecast Omicron disruptions could cause its business to contract in the second quarter Key Takeways: Full Truck Alliance shares are up 60% from a mid-March low, including a 32% gain since Friday, on reports that Beijing may ease its regulatory oversight of big tech companies Company is currently undergoing a data security review and said its business could contract in the second quarter due to Omicron-related disruptions By Doug Young When are mass disruptions…

Read More »